Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs-Reference-Cited by-同舟云学术

Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs

Published:2013-02-27 Issue:8 Volume:26 Page:771-777
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

van Gelder Teun¹,Gabardi Steven²

Affiliation:

1. Departments of Hospital Pharmacy and Internal Medicine; Erasmus Medical Center; CA; Rotterdam; The Netherlands

2. Departments of Transplant Surgery and Pharmacy Services, and the Renal Division; Brigham and Women's Hospital; Harvard Medical School; Boston; MA; USA

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12074/fullpdf

Reference37 articles.

1. Generic Pharmaceutical Association 2010 www.gphaonline.org

2. The ongoing regulation of generic drugs;Frank;New Engl J Med,2007

3. CONSENT: Consensus on Substitution in European Transplantation. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A;Pollard;Clin Ther,2003

4. Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory;Uber;J Heart Lung Transplant,2009

5. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group;KDIGO clinical practice guideline for the care of kidney transplant recipients;Am J Transplant,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic Medicinal Products in Immunosuppressive Therapy—Should It be a Challenge for Therapeutic Drug Monitoring?;Therapeutic Drug Monitoring;2023-04

2. Assessment of Prescribability and Switchability by Using Multiple Bioequivalence Assessment Approaches;Drug Metabolism Letters;2021-11-22

3. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology;Therapeutic Drug Monitoring;2021-04

4. Comparison of clinical effects, trough and peak levels between branded and generic formulation of Cyclosporine in stable psoriatic patients;Giornale Italiano di Dermatologia e Venereologia;2020-10

Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus

;Drug, Healthcare and Patient Safety;2020-09